BACKGROUND: The relationship between gestation, childbirth and cancer prognosis is unknown for most cancers (e.g. Hodgkin lymphoma), whereas a body of evidence exists for melanoma and breast cancer. METHODS: The national cancer registration and hospital discharge data for women in England (1998-2007) were linked, and the records for Hodgkin lymphoma, melanoma and breast cancer were indexed as to whether women had delivered a child in separate time periods prior to their cancer diagnosis. Survival analyses were conducted in order to characterise prognosis in relation to childbirth, with statistical adjustment for age and (where possible) stage. FINDINGS: For melanoma and breast cancer, survival was strongly reduced in women who gave birth in the year prior to cancer diagnosis. The age-adjusted hazard ratios (HR) with 95% confidence intervals (CI) were 2.06 (1.42-3.01) for melanoma and 1.84 (1.64-2.06) for breast cancer. The associations were only slightly attenuated by further adjustment for tumour stage. For breast cancer, the excess death rate in women with a recent childbirth peaked at 2 years and remained elevated for 6 to 8 years. Previous childbirth had no overall effect on the outcome of Hodgkin lymphoma. INTERPRETATION: Melanoma and breast cancer prognosis are adversely affected by recent gestation and childbirth in a way that is not due to stage of the cancer, but rather to inherent biological properties of the tumours. Possible biological mechanisms include immunosuppression (melanoma), the hormonal milieu in gestation and a tumour promoting microenvironment post-partum (breast cancer).
BACKGROUND: The relationship between gestation, childbirth and cancer prognosis is unknown for most cancers (e.g. Hodgkin lymphoma), whereas a body of evidence exists for melanoma and breast cancer. METHODS: The national cancer registration and hospital discharge data for women in England (1998-2007) were linked, and the records for Hodgkin lymphoma, melanoma and breast cancer were indexed as to whether women had delivered a child in separate time periods prior to their cancer diagnosis. Survival analyses were conducted in order to characterise prognosis in relation to childbirth, with statistical adjustment for age and (where possible) stage. FINDINGS: For melanoma and breast cancer, survival was strongly reduced in women who gave birth in the year prior to cancer diagnosis. The age-adjusted hazard ratios (HR) with 95% confidence intervals (CI) were 2.06 (1.42-3.01) for melanoma and 1.84 (1.64-2.06) for breast cancer. The associations were only slightly attenuated by further adjustment for tumour stage. For breast cancer, the excess death rate in women with a recent childbirth peaked at 2 years and remained elevated for 6 to 8 years. Previous childbirth had no overall effect on the outcome of Hodgkin lymphoma. INTERPRETATION:Melanoma and breast cancer prognosis are adversely affected by recent gestation and childbirth in a way that is not due to stage of the cancer, but rather to inherent biological properties of the tumours. Possible biological mechanisms include immunosuppression (melanoma), the hormonal milieu in gestation and a tumour promoting microenvironment post-partum (breast cancer).
Authors: Dimitrios C Ziogas; Panagiotis Diamantopoulos; Olga Benopoulou; Amalia Anastasopoulou; Dimitrios Bafaloukos; Alexander J Stratigos; John M Kirkwood; Helen Gogas Journal: Oncologist Date: 2020-04-09
Authors: Anna Morra; Audrey Y Jung; Marjanka K Schmidt; Jenny Chang-Claude; Sabine Behrens; Renske Keeman; Thomas U Ahearn; Hoda Anton-Culver; Volker Arndt; Annelie Augustinsson; Päivi K Auvinen; Laura E Beane Freeman; Heiko Becher; Matthias W Beckmann; Carl Blomqvist; Stig E Bojesen; Manjeet K Bolla; Hermann Brenner; Ignacio Briceno; Sara Y Brucker; Nicola J Camp; Daniele Campa; Federico Canzian; Jose E Castelao; Stephen J Chanock; Ji-Yeob Choi; Christine L Clarke; Fergus J Couch; Angela Cox; Simon S Cross; Kamila Czene; Thilo Dörk; Alison M Dunning; Miriam Dwek; Douglas F Easton; Diana M Eccles; Kathleen M Egan; D Gareth Evans; Peter A Fasching; Henrik Flyger; Manuela Gago-Dominguez; Susan M Gapstur; José A García-Sáenz; Mia M Gaudet; Graham G Giles; Mervi Grip; Pascal Guénel; Christopher A Haiman; Niclas Håkansson; Per Hall; Ute Hamann; Sileny N Han; Steven N Hart; Mikael Hartman; Jane S Heyworth; Reiner Hoppe; John L Hopper; David J Hunter; Hidemi Ito; Agnes Jager; Milena Jakimovska; Anna Jakubowska; Wolfgang Janni; Rudolf Kaaks; Daehee Kang; Pooja Middha Kapoor; Cari M Kitahara; Stella Koutros; Peter Kraft; Vessela N Kristensen; James V Lacey; Diether Lambrechts; Loic Le Marchand; Jingmei Li; Annika Lindblom; Jan Lubiński; Michael Lush; Arto Mannermaa; Mehdi Manoochehri; Sara Margolin; Shivaani Mariapun; Keitaro Matsuo; Dimitrios Mavroudis; Roger L Milne; Taru A Muranen; William G Newman; Dong-Young Noh; Børge G Nordestgaard; Nadia Obi; Andrew F Olshan; Håkan Olsson; Tjoung-Won Park-Simon; Christos Petridis; Paul D P Pharoah; Dijana Plaseska-Karanfilska; Nadege Presneau; Muhammad U Rashid; Gad Rennert; Hedy S Rennert; Valerie Rhenius; Atocha Romero; Emmanouil Saloustros; Elinor J Sawyer; Andreas Schneeweiss; Lukas Schwentner; Christopher Scott; Mitul Shah; Chen-Yang Shen; Xiao-Ou Shu; Melissa C Southey; Daniel O Stram; Rulla M Tamimi; William Tapper; Rob A E M Tollenaar; Ian Tomlinson; Diana Torres; Melissa A Troester; Thérèse Truong; Celine M Vachon; Qin Wang; Sophia S Wang; Justin A Williams; Robert Winqvist; Alicja Wolk; Anna H Wu; Keun-Young Yoo; Jyh-Cherng Yu; Wei Zheng; Argyrios Ziogas; Xiaohong R Yang; A Heather Eliassen; Michelle D Holmes; Montserrat García-Closas; Soo Hwang Teo Journal: Cancer Epidemiol Biomarkers Prev Date: 2021-01-26 Impact factor: 4.090
Authors: Hongki Gwak; Sang Seok Woo; Eun-Sook Lee; Min Ho Park; Seokwon Lee; Hyun Jo Youn; Seho Park; In Suck Suh; Seong Hwan Kim Journal: Medicine (Baltimore) Date: 2022-10-07 Impact factor: 1.817